Work

In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides

Year: 2015

Type: article

Source: Journal of Hepatology

DOI: 10.1016/j.jhep.2015.11.032

Authors: Gaetan Billioud, Robert L. Kruse, Melissa Carrillo, Christina Whitten-Bauer, Dacao Gao, Aneeza Kim, Leon Chen, Michael L. McCaleb, Jeffrey R. Crosby, Robert Hamatake, Zhi Hong, Urtzi Garaigorta, Eric Swayze, Karl-Dimiter Bissig, Stefan Wieland

Institutions: Scripps Research Institute, Baylor College of Medicine, Ionis Pharmaceuticals (United States)

Language: English

Topic: Hepatitis B Virus Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1404346693, G329313437, Animal Models for Lipid Metabolism , Hematology Training Program, Antisense Mediated Treatment of Hepatitis B Virus Infection, Diabetes Endocrinology Research Center

OpenAlex ID: W2183502108

FWCI: 3.927

Cites: 59

Cited by: 53

Related to: 10